{"id":270262,"date":"2025-01-15T07:00:22","date_gmt":"2025-01-15T13:00:22","guid":{"rendered":"https:\/\/dallasinnovates.com\/?p=270262"},"modified":"2025-01-22T15:33:42","modified_gmt":"2025-01-22T21:33:42","slug":"dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding","status":"publish","type":"post","link":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/","title":{"rendered":"Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding"},"content":{"rendered":"

Dallas-based Colossal Biosciences is making history\u2014again. <\/p>\n

<\/strong>The world\u2019s first de-extinction company, founded in 2021<\/a> by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, has become Texas\u2019 first \u201cdecacorn\u201d\u2014startup speak for a private company valued at more than $10 billion\u2014after securing $200 million in new funding.<\/p>\n

<\/strong>The biotech with a bold mission to bring back the woolly mammoth and other extinct species joins an elite group of about 75 private companies<\/a> worldwide with this designation.<\/p>\n

But for Colossal CEO and co-founder Ben Lamm, the milestone is just the beginning. A serial entrepreneur driven by impact, Lamm sees a future where revolutionary science and technology can reshape entire ecosystems.<\/p>\n

\u201cThe core of Colossal is a trillion-dollar opportunity,\u201d he told Dallas Innovates, aiming to deliver wins for both conservationists and investor boardrooms.<\/p>\n

The Series C funding round, led by TWG Global with participation from other prominent backers, pushes its valuation to $10.2 billion and its total funding to $435 million since launch.<\/p>\n

Lamm says the company’s recent successes in “creating the technologies necessary for our end-to-end de-extinction toolkit” were met with enthusiasm by the investor community. “TWG Global and our other partners have been bullish in their desire to help us scale as quickly and efficiently as possible,” he said.<\/p>\n

In a statement, Mark Walter, CEO of TWG Global, said his firm was drawn to Colossal’s position at “the intersection of AI, computational biology and genetic engineering.”\u00a0 The firm, a diversified holding company with investments spanning technology, financial services, and sports media, sees potential beyond de-extinction.<\/p>\n

“Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation,” Walter added. In just under four years, Colossal has established a global scientific operation employing more than 170 scientists across facilities in Dallas, Boston, and Melbourne, Australia. <\/p>\n

The new funding will expand the Colossal team, advance new technologies, and grow its de-extinction species list\u2014all while driving its mission to make extinction a thing of the past, Lamm says.
\n<\/span><\/p>\n

\"\"

Colossal Biosciences co-founders Ben Lamm and George Church. [Photo: Colossal Biosciences]<\/p><\/div>\n

A new biotech frontier<\/h3>\n

\u201cColossal is a revolutionary genetics company making science fiction into science fact,\u201d said co-founder George Church, a Professor of Genetics at Harvard Medical School who also holds positions at MIT and Harvard.<\/p>\n

“We are creating the technology to build de-extinction science and scale conservation biology, particularly for endangered and at-risk species,” he said. “I could not be more appreciative of the investor support for this important mission.”<\/p>\n

It\u2019s a moonshot, for sure, but one grounded in meticulous science.
\n<\/span><\/p>\n

Colossal\u2019s flagship projects to revive the woolly mammoth, thylacine (Tasmanian tiger)<\/a>, and dodo capture the public imagination. But these efforts, Lamm says, are driving innovations with far-reaching implications. The genetic engineering and computational breakthroughs developed for de-extinction are already advancing biodiversity conservation, endangered species preservation, and more.<\/p>\n

Lamm highlights significant progress in genome editing, stem cell generation, and embryology. Among its achievements, the company has generated the first de novo assembled mammoth genome and engineered elephant stem cells\u2014breakthroughs already aiding endangered species like elephants. Colossal has also hatched its first chimeric chicks as part of the dodo revival program.
\n<\/span><\/p>\n

\"\"

Colossal Foundation Executive Director Matt James (center) with Colossal’s head of animal husbandry, Steve Metzler, and Wendy Kiso, Colossal’s principal scientist for assisted reproduction. [Photo: Colossal Biosciences}<\/p><\/div>\n

Conservation impact<\/span><\/h3>\n
\u00a0<\/div>\n

Beyond its headline-grabbing de-extinction work, Colossal has expanded its conservation efforts through The Colossal Foundation<\/a>, a 501(c)(3) established in October 2024 that now supports 48 conservation partners worldwide.<\/p>\n

The stakes couldn\u2019t be higher. According to Colossal, the world is losing 27,000 species a year, far exceeding the natural extinction rate. The cascading effects of biodiversity loss\u2014water scarcity, food insecurity, ecosystem collapse\u2014pose existential threats to humanity.<\/p>\n

Colossal\u2019s technology aims to combat these crises. Its work on the woolly mammoth, for instance, involves genetic adaptations that could rewild the tundra, slowing permafrost thaw and mitigating climate change. Meanwhile, the dodo project<\/a> is creating avian genetic tools to benefit endangered bird species.<\/p>\n

Beth Shapiro, Colossal\u2019s chief science officer, emphasized the company\u2019s advances in de-extinction and what’s next. “While the path to de-extinction is complex, each step forward brings us closer to understanding how we might responsibly reintroduce traits from lost species,” she said.<\/span><\/p>\n

“The technological advances we’re seeing in genetic engineering and synthetic biology are rapidly transforming our understanding of what’s possible in species restoration,\u201d said Shapiro. “The real promise lies not just in the technology, but also in how we might apply these tools to protect and restore endangered species and ecosystems.\u201d\u00a0<\/p>\n

\"\"

Beth Shapiro, Colossal\u2019s chief science officer and an ancient DNA expert<\/a><\/span>, left, with CEO Ben Lamm in the lab. [Photo: Colossal Biosciences]<\/p><\/div>\n

The road ahead<\/h3>\n

Building Colossal\u2019s vision is no small feat. \u201cIt takes a village to raise a child,” Lamm said. \u201cAnd it takes an international consortium to bring back species and save species.\u201d With its team of scientists, over 95 scientific advisors, and more than 40 postdoctoral researchers across 17 global labs, Colossal is orchestrating what he describes as an unprecedented collaborative effort.<\/p>\n

The vision has drawn backing from strategic investors including TWG Global, USIT, Animal Capital, and Breyer Capital, as well as private supporters like filmmakers Peter Jackson and Fran Walsh and biotech heavyweights such as Tim Draper and TWG Global\u2019s Mark Walter. \u201cWe\u2019ve been fortunate to partner with people who think in 25- to 50-year horizons,\u201d Lamm said, emphasizing the patience and foresight required to address systemic challenges like biodiversity loss.<\/p>\n

This collaboration, Lamm believes, is fueled by the urgency of the problem Colossal aims to solve. “Outside of climate change and becoming an interplanetary species, there’s probably not a lot of existential threats as important as the loss of biodiversity,” he said.<\/p>\n

For Lamm, the valuation of $10.2 billion\u2014the milestone that makes Colossal Texas\u2019 first decacorn\u2014is secondary to the impact. \u201cThe funding is an empowerment to the scientists around the movement,\u201d he explained. \u201cIt\u2019s humbling that every single press release we do has multiple world firsts, many of which people said we\u2019d never achieve.\u201d<\/p>\n

Beyond de-extinction, he sees the company’s ripple effects driving advances in areas like human health and agriculture.<\/p>\n

\"\"

Colossal CSO Beth Shapiro and CEO Ben Lamm with a stuffed dodo. [Photo: Colossal Biosciences]<\/p><\/div>\n

Looking ahead, Colossal’s goals include breakthroughs like achieving live births of de-extinct species, furthering artificial womb development, and expanding efforts in rewilding. \u201cSuccess isn\u2019t just creating five dodos,\u201d Lamm told us. \u201cIt\u2019s hundreds of dodos with genetic diversity, thriving back in Mauritius and neighboring islands.\u201d<\/p>\n

Ultimately, Colossal aims to inspire and enable transformative change\u2014not only in conservation but in how the world approaches its greatest challenges. \u201cIf we can create economic value, make a positive impact, and inspire the next generation,\u201d Lamm said, \u201cthen we\u2019re doing something right.\u201d<\/p>\n

Founded and headquartered in Dallas, where Lamm moved from Austin in 2016, Colossal has expanded into a global operation. \u201cWe\u2019re doing this in Texas, which is awesome,\u201d he said. \u201cIt shows the world that you can build really valuable companies here.\u201d<\/p>\n

\n

Don’t miss what’s next. Subscribe\u00a0to\u00a0Dallas\u00a0Innovates.<\/h2>\n

Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.<\/p>\n

\n
\n
One quick signup, and you’re done.<\/p>\n
<\/div>\n<\/div>\n<\/form>\n<\/div>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world’s first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth’s lost biodiversity, “making science fiction into science fact.”<\/p>\n","protected":false},"author":8,"featured_media":270319,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8,179948,15],"tags":[174641,2751,194915,1254,201870,172675,199858,201871,189375,9007,194670,180938,172413,199606,7043,201868,201869],"class_list":["post-270262","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-enterprise","category-follow-the-money","category-startup","tag-animal-capital","tag-ben-lamm","tag-beth-shapiro","tag-biotech","tag-breyer-capitalthomas-tull","tag-colossal-biosciences","tag-colossal-foundation","tag-fran-walsh","tag-george-church","tag-harvard","tag-harvard-medical-school","tag-mark-walter","tag-mit","tag-peter-jackson","tag-tim-draper","tag-twg-global","tag-usit"],"acf":[],"yoast_head":"\nDallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding » Dallas Innovates<\/title>\n<meta name=\"description\" content=\"Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding\" \/>\n<meta property=\"og:description\" content=\"Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Dallas Innovates\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/dallasinnovates\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T13:00:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-22T21:33:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"970\" \/>\n\t<meta property=\"og:image:height\" content=\"463\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Quincy Preston\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@quincypreston\" \/>\n<meta name=\"twitter:site\" content=\"@dallasinnovates\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Quincy Preston\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\"},\"author\":{\"name\":\"Quincy Preston\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/person\/31d96a1ad48d703a6b72c03a291cd710\"},\"headline\":\"Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding\",\"datePublished\":\"2025-01-15T13:00:22+00:00\",\"dateModified\":\"2025-01-22T21:33:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\"},\"wordCount\":1265,\"publisher\":{\"@id\":\"https:\/\/dallasinnovates.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg\",\"keywords\":[\"Animal Capital\",\"Ben Lamm\",\"beth shapiro\",\"biotech\",\"Breyer CapitalThomas Tull\",\"Colossal Biosciences\",\"Colossal Foundation\",\"Fran Walsh\",\"George Church\",\"Harvard\",\"Harvard Medical School\",\"Mark Walter\",\"MIT\",\"Peter Jackson\",\"Tim Draper\",\"TWG Global\",\"USIT\"],\"articleSection\":[\"Business\",\"Follow the Money\",\"Startup\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/dallasinnovates.com\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\",\"url\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\",\"name\":\"Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding » Dallas Innovates\",\"isPartOf\":{\"@id\":\"https:\/\/dallasinnovates.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg\",\"datePublished\":\"2025-01-15T13:00:22+00:00\",\"dateModified\":\"2025-01-22T21:33:42+00:00\",\"description\":\"Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.\",\"breadcrumb\":{\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage\",\"url\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg\",\"contentUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg\",\"width\":970,\"height\":463,\"caption\":\"Ben Lamm at the Colossal Lab in Dallas. [Photo: Colossal Biosciences]\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dallasinnovates.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dallasinnovates.com\/#website\",\"url\":\"https:\/\/dallasinnovates.com\/\",\"name\":\"Dallas Innovates\",\"description\":\"What's new + next in Dallas - Fort Worth\",\"publisher\":{\"@id\":\"https:\/\/dallasinnovates.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dallasinnovates.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/dallasinnovates.com\/#organization\",\"name\":\"Dallas Innovates | Published by Dallas Next\",\"url\":\"https:\/\/dallasinnovates.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg\",\"contentUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg\",\"width\":1782,\"height\":410,\"caption\":\"Dallas Innovates | Published by Dallas Next\"},\"image\":{\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/dallasinnovates\/\",\"https:\/\/x.com\/dallasinnovates\",\"https:\/\/www.instagram.com\/dallasinnovates\/\",\"https:\/\/www.linkedin.com\/company\/dallas-innovates\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/person\/31d96a1ad48d703a6b72c03a291cd710\",\"name\":\"Quincy Preston\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a7b6237fd07da03813670ac36e1677b49e7d53f115936e2c32e5eb4a63a263e3?s=96&d=retro&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a7b6237fd07da03813670ac36e1677b49e7d53f115936e2c32e5eb4a63a263e3?s=96&d=retro&r=g\",\"caption\":\"Quincy Preston\"},\"description\":\"Quincy Preston is fueled by an entrepreneurial spark and driven by mission. Preston launched the Dallas Innovates' media platform to tell the story of innovation in Dallas-Fort Worth. It was official in 2016 when the Dallas skyline turned purple for innovation. Since then, Dallas Innovates has become a must-read among business leaders and forward thinkers in North Texas. \\\"Our partners call us 'the tip of the spear for innovation news in North Texas,'\\\" she says. \\\"Now it's our tagline.\\\" The media-with-a-mission brand covers what's new and next in North Texas business. \\\"Our lens is lift,\\\" Preston says. \\\"We want to inspire ideas and opportunity. We're a catalyst for connections, here and beyond.\\\" Covering the Dallas-Fort Worth Innovation Economy \\\"Dallas-Fort Worth has all of the core assets that drive an innovation economy,\\\" Preston told D CEO about the launch. \\\"We felt Dallas Innovates could be the center of innovation in business in DFW, from startup to enterprise, and include all the great impact work happening here.\\\" One of our superpowers is our diverse economy: \\\"A lot of places want one thing to hang their hat on, but DFW has many centers of innovation,\\\" she noted. \\\"And the fact that small businesses can work with very large companies here as a Fortune 50 market is a huge advantage.\\\" Preston founded media company Dallas Next in 2021 and publishes Dallas Innovates in a collaboration with the Dallas Regional Chamber. DRC innovation and research chief Duane Dankesreiter and Dallas Innovates co-founder says it's \\\"the drumbeat\\\" for the innovation economy in the region. Dallas Next also publishes the DALLAS\u00ae publications in partnership with the DRC. Dallas Innovates' sister publications include the DALLAS\u00ae Regional Economic Development Guide, the DALLAS\u00ae Relocation + Newcomers Guide, and the\u00a0DALLAS\u00ae Commercial Real Estate, which is a partnership with the DRC and The Real Estate Council. \\\"It's hard to say no to Quincy Preston when she believes in something,\\\" wrote D CEO Editor Christine Perez in the magazine. \\\"She won't stop until she makes it happen.\\\" In a previous role at D Magazine Partners, Preston incubated Dallas Innovates and published the DRC's brand publications. There, she also led the launch of D Healthcare Daily at D CEO and the launch of D TV. Preston developed data solutions to provide insights and measurement for growth across D Magazine Partners brands. Preston has worn many hats in her media career, including stints as a writer, photographer, and award-winning designer. During her long tenure at the Dallas Business Journal, Preston managed budgets, project schedules, resources, and talent; she also developed several cost-saving and income-producing initiatives that were adopted across the ACBJ chain of more than 40 newspapers. Preston's first editorial job was working for a fashion magazine at the Dallas Apparel Mart with an office a few doors down from Lucy Billingsley, daughter of legendary real estate developer Trammell Crow. At the time, Billingsley was running the market center where she led three expansions and a ~7 million-square-foot development. It was good company to be in. Later, when Preston launched an agency that she ran through the early nineties, Billingsley helped her with tough-but-kind advice\u2014and some pivotal connections. Today, Preston helms Dallas Innovates and the DALLAS\u00ae publications group, published by Dallas Next for the Dallas Regional Chamber. The growing DALLAS\u00ae platform includes sister publication Dallas Innovates. Together they focus on Dallas-Fort Worth business, including real estate, relocation, economic development, and innovation. Connect on social media: LinkedIn, Twitter\u00a0 Send news and tips here.\",\"sameAs\":[\"http:\/\/www.dallasinnovates.com\",\"https:\/\/x.com\/quincypreston\"],\"url\":\"https:\/\/dallasinnovates.com\/author\/quincy-preston\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding » Dallas Innovates","description":"Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/","og_locale":"en_US","og_type":"article","og_title":"Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding","og_description":"Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.","og_url":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/","og_site_name":"Dallas Innovates","article_publisher":"https:\/\/www.facebook.com\/dallasinnovates\/","article_published_time":"2025-01-15T13:00:22+00:00","article_modified_time":"2025-01-22T21:33:42+00:00","og_image":[{"width":970,"height":463,"url":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg","type":"image\/jpeg"}],"author":"Quincy Preston","twitter_card":"summary_large_image","twitter_creator":"@quincypreston","twitter_site":"@dallasinnovates","twitter_misc":{"Written by":"Quincy Preston","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#article","isPartOf":{"@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/"},"author":{"name":"Quincy Preston","@id":"https:\/\/dallasinnovates.com\/#\/schema\/person\/31d96a1ad48d703a6b72c03a291cd710"},"headline":"Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding","datePublished":"2025-01-15T13:00:22+00:00","dateModified":"2025-01-22T21:33:42+00:00","mainEntityOfPage":{"@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/"},"wordCount":1265,"publisher":{"@id":"https:\/\/dallasinnovates.com\/#organization"},"image":{"@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg","keywords":["Animal Capital","Ben Lamm","beth shapiro","biotech","Breyer CapitalThomas Tull","Colossal Biosciences","Colossal Foundation","Fran Walsh","George Church","Harvard","Harvard Medical School","Mark Walter","MIT","Peter Jackson","Tim Draper","TWG Global","USIT"],"articleSection":["Business","Follow the Money","Startup"],"inLanguage":"en-US","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/dallasinnovates.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/","url":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/","name":"Dallas' Colossal Biosciences Becomes Texas' First Decacorn, Securing $10.2B Valuation With Series C Funding » Dallas Innovates","isPartOf":{"@id":"https:\/\/dallasinnovates.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage"},"image":{"@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg","datePublished":"2025-01-15T13:00:22+00:00","dateModified":"2025-01-22T21:33:42+00:00","description":"Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.","breadcrumb":{"@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#primaryimage","url":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg","contentUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2025\/01\/Colossal_BL_Lab_Entran.jpg","width":970,"height":463,"caption":"Ben Lamm at the Colossal Lab in Dallas. [Photo: Colossal Biosciences]"},{"@type":"BreadcrumbList","@id":"https:\/\/dallasinnovates.com\/dallas-colossal-biosciences-becomes-texas-first-decacorn-securing-10-2b-valuation-with-series-c-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dallasinnovates.com\/"},{"@type":"ListItem","position":2,"name":"Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding"}]},{"@type":"WebSite","@id":"https:\/\/dallasinnovates.com\/#website","url":"https:\/\/dallasinnovates.com\/","name":"Dallas Innovates","description":"What's new + next in Dallas - Fort Worth","publisher":{"@id":"https:\/\/dallasinnovates.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dallasinnovates.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/dallasinnovates.com\/#organization","name":"Dallas Innovates | Published by Dallas Next","url":"https:\/\/dallasinnovates.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/","url":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg","contentUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg","width":1782,"height":410,"caption":"Dallas Innovates | Published by Dallas Next"},"image":{"@id":"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/dallasinnovates\/","https:\/\/x.com\/dallasinnovates","https:\/\/www.instagram.com\/dallasinnovates\/","https:\/\/www.linkedin.com\/company\/dallas-innovates"]},{"@type":"Person","@id":"https:\/\/dallasinnovates.com\/#\/schema\/person\/31d96a1ad48d703a6b72c03a291cd710","name":"Quincy Preston","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dallasinnovates.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a7b6237fd07da03813670ac36e1677b49e7d53f115936e2c32e5eb4a63a263e3?s=96&d=retro&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a7b6237fd07da03813670ac36e1677b49e7d53f115936e2c32e5eb4a63a263e3?s=96&d=retro&r=g","caption":"Quincy Preston"},"description":"Quincy Preston is fueled by an entrepreneurial spark and driven by mission. Preston launched the Dallas Innovates' media platform to tell the story of innovation in Dallas-Fort Worth. It was official in 2016 when the Dallas skyline turned purple for innovation. Since then, Dallas Innovates has become a must-read among business leaders and forward thinkers in North Texas. \"Our partners call us 'the tip of the spear for innovation news in North Texas,'\" she says. \"Now it's our tagline.\" The media-with-a-mission brand covers what's new and next in North Texas business. \"Our lens is lift,\" Preston says. \"We want to inspire ideas and opportunity. We're a catalyst for connections, here and beyond.\" Covering the Dallas-Fort Worth Innovation Economy \"Dallas-Fort Worth has all of the core assets that drive an innovation economy,\" Preston told D CEO about the launch. \"We felt Dallas Innovates could be the center of innovation in business in DFW, from startup to enterprise, and include all the great impact work happening here.\" One of our superpowers is our diverse economy: \"A lot of places want one thing to hang their hat on, but DFW has many centers of innovation,\" she noted. \"And the fact that small businesses can work with very large companies here as a Fortune 50 market is a huge advantage.\" Preston founded media company Dallas Next in 2021 and publishes Dallas Innovates in a collaboration with the Dallas Regional Chamber. DRC innovation and research chief Duane Dankesreiter and Dallas Innovates co-founder says it's \"the drumbeat\" for the innovation economy in the region. Dallas Next also publishes the DALLAS\u00ae publications in partnership with the DRC. Dallas Innovates' sister publications include the DALLAS\u00ae Regional Economic Development Guide, the DALLAS\u00ae Relocation + Newcomers Guide, and the\u00a0DALLAS\u00ae Commercial Real Estate, which is a partnership with the DRC and The Real Estate Council. \"It's hard to say no to Quincy Preston when she believes in something,\" wrote D CEO Editor Christine Perez in the magazine. \"She won't stop until she makes it happen.\" In a previous role at D Magazine Partners, Preston incubated Dallas Innovates and published the DRC's brand publications. There, she also led the launch of D Healthcare Daily at D CEO and the launch of D TV. Preston developed data solutions to provide insights and measurement for growth across D Magazine Partners brands. Preston has worn many hats in her media career, including stints as a writer, photographer, and award-winning designer. During her long tenure at the Dallas Business Journal, Preston managed budgets, project schedules, resources, and talent; she also developed several cost-saving and income-producing initiatives that were adopted across the ACBJ chain of more than 40 newspapers. Preston's first editorial job was working for a fashion magazine at the Dallas Apparel Mart with an office a few doors down from Lucy Billingsley, daughter of legendary real estate developer Trammell Crow. At the time, Billingsley was running the market center where she led three expansions and a ~7 million-square-foot development. It was good company to be in. Later, when Preston launched an agency that she ran through the early nineties, Billingsley helped her with tough-but-kind advice\u2014and some pivotal connections. Today, Preston helms Dallas Innovates and the DALLAS\u00ae publications group, published by Dallas Next for the Dallas Regional Chamber. The growing DALLAS\u00ae platform includes sister publication Dallas Innovates. Together they focus on Dallas-Fort Worth business, including real estate, relocation, economic development, and innovation. Connect on social media: LinkedIn, Twitter\u00a0 Send news and tips here.","sameAs":["http:\/\/www.dallasinnovates.com","https:\/\/x.com\/quincypreston"],"url":"https:\/\/dallasinnovates.com\/author\/quincy-preston\/"}]}},"_links":{"self":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/posts\/270262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/comments?post=270262"}],"version-history":[{"count":0,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/posts\/270262\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/media\/270319"}],"wp:attachment":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/media?parent=270262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/categories?post=270262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/tags?post=270262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}